Biostage, Inc. (BSTG) Research

Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to address esophageal cancer. Founded in 2009, the organization was formerly known as Harvard Apparatus Regenerative Technology, Inc. before rebranding as Biostage, Inc. in March 2016. Its corporate headquarters are located in Holliston, Massachusetts.

Market snapshot

Symbol
BSTG
Price
$4.03
Day change
+0.75%
Market cap
$21.7M
P/E ratio
-3.19x
52-week range
3.65-9.0
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • E-therapeutics Plc (ETXPF)
  • Goodness Growth Holdings, Inc. (GDNSF)
  • Herantis Pharma Oyj (HRPMF)
  • Karolinska Development AB (publ) (KDEVF)
  • MCI Onehealth Technologies Inc. (MCIOF)
  • Mindset Pharma Inc. (MSSTF)
  • Medivir AB (publ) (MVRBF)
  • Abliva AB (publ) (NEVPF)

Open Biostage, Inc. (BSTG) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.